Revance Therapeutics
RVNC
£2.81
Share price
0.00%
Change (1 day)
-21.76%
Change (1 year)
Categories
Revance Therapeutics (RVNC) - Cash on Hand
Cash on Hand as of September 2024 : £0.14 Billion
According to Revance Therapeutics's latest financial reports the company has £0.14 Billion in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Revance Therapeutics - Cash on Hand chart (from 2012 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | £0.19 B | -29.23% |
| 2022-12-31 | £0.28 B | 68.9% |
| 2021-12-31 | £0.16 B | -47.93% |
| 2020-12-31 | £0.32 B | 44.75% |
| 2019-12-31 | £0.22 B | 59.74% |
| 2018-12-31 | £0.13 B | -33.83% |
| 2017-12-31 | £0.20 B | 39.21% |
| 2016-12-31 | £0.15 B | -11.69% |
| 2015-12-31 | £0.17 B | 54.98% |
| 2014-12-31 | £0.10 B | 4529.67% |
| 2013-12-31 | £2.37 M | -6.07% |
| 2012-12-31 | £2.52 M | -86.74% |
| 2011-12-31 | £19.05 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 | £31.11 M | -78.07% | 🇺🇸 USA |
 | £18.90 B | 13,221.67% | 🇺🇸 USA |
 | £1.83 B | 1,190.23% | 🇺🇸 USA |